Ownership history in Checkpoint Capital L.P. · 9 quarters on record
This page tracks every 13F SEC filing in which Checkpoint Capital L.P. reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 992,200 | +228,493 | +29.9% | 33.18% | $106.2M | $107.04 |
| 2025 Q3 | REDUCED | 763,707 | -296,293 | -28.0% | 25.84% | $77.1M | $100.99 |
| 2025 Q2 | ADDED | 1,060,000 | +152,760 | +16.8% | 31.21% | $67.0M | $63.19 |
| 2025 Q1 | ADDED | 907,240 | +179,258 | +24.6% | 26.37% | $48.1M | $52.97 |
| 2024 Q4 | ADDED | 727,982 | +64,601 | +9.7% | 20.74% | $40.8M | $55.98 |
| 2024 Q3 | REDUCED | 663,381 | -258,719 | -28.1% | 17.24% | $34.8M | $52.39 |
| 2024 Q2 | ADDED | 922,100 | +96,600 | +11.7% | 22.82% | $37.9M | $41.06 |
| 2024 Q1 | ADDED | 825,500 | +95,500 | +13.1% | 23.91% | $35.8M | $43.33 |
| 2023 Q4 | INITIATED | 730,000 | — | — | 20.33% | $33.6M | — |
As of 2025 Q4 — sorted by position size